Dalfampridine 10MG SA tablets
Ended Awarded
- Contract number
- VA77017J0720
- Awardee
-
Acorda Therapeutics, Inc. UEI R5D3FUPFFPK4
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $485,835
Award facts
- Contract value 100% obligated
- $485,835.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Veterans Integrated Service Network 12 Veterans Health Administration, Department of Veterans Affairs
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Ardsley, NY 10502, USA
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company that specializes in developing and commercializing therapies for neurological disorders. The contract is for the supply of Dalfampridine 10mg sustained-action (SA) tablets, a medication used to treat multiple sclerosis. The contract has a ceiling value of $485,835.00 and is a firm fixed-price delivery order, with no set-aside designation. This contract is issued under Acorda's existing Federal Supply Schedule (FSS) contract with the VA, which is valued at over $16.3 million and facilitates the procurement of the company's pharmaceutical products by the VA. Additionally, Acorda holds two Blanket Purchase Agreements (BPAs) with the VA National Acquisition Center, valued at $5.5 million and $7.5 million, specifically for the procurement of Inbrija and Ampyra, other neurological medications developed by the company. These contract vehicles support the VA's mission to provide quality healthcare to veterans suffering from conditions like Parkinson's disease and multiple sclerosis.
Quick answers
Who was awarded contract VA77017J0720?
VA77017J0720 was awarded to Acorda Therapeutics, Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on March 15, 2017.
How much is contract VA77017J0720 worth?
The government has obligated $485,835 on VA77017J0720.
Which agency awarded contract VA77017J0720?
Veterans Integrated Service Network 15 (Veterans Health Administration) awarded VA77017J0720, with funding from Veterans Integrated Service Network 12 (Veterans Health Administration).
Is contract VA77017J0720 an order under another contract?
Yes. VA77017J0720 is a delivery order under V797P5233B, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA77017J0720 competed?
The extent of competition for VA77017J0720 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award